December 23, 2022
The Week’s Biggest Winner & Loser
Nike (NKE)
Nike (NKE) once again proved why I often say, “In Nike, we trust” when it reported a blowout earnings report on Tuesday, surprising analysts and causing a pretty significant market rally to kick off on Wednesday. Nike popped +9.72% in an otherwise middling week, easily earning it the spot of the Week’s Biggest Winner.
Tesla (TSLA)
Despite having an epically bad couple of months, Tesla (TSLA), which has been freefall since CEO Elon Musk bought the social media platform, finally made it on to the Week’s Biggest Loser list this week, dropping another epic -18.04% in a single week (… and this is after it’s dropped that much or more for the past 3-4 weeks!!!)
Portfolio Allocation
Positions
%
Target Position Size
The “Baskets”
The Investments in Play portfolio contains a number of groups of stocks called “baskets.” I use baskets when I want exposure to a certain sector, but I want to use more than one stock to get that exposure without giving each individual stock an allocation.
In this portfolio, there is the Financials Basket which includes stocks that provide the portfolio with exposure to the financial sector which includes money-center banks, credit card companies, and investment management firms.
The Pets Basket includes the two leaders in pet health, long-time holding IDEXX Labs (IDXX) and newcomer Zoetis (ZTS). Both are considered “Best-in-Breed” (pun intended) for different reasons which is why I’m holding both of them instead of just picking one or over the other.
Additionally, there are two speculative baskets in the portfolio: Old-Spec and New-Spec.
Companies in the Old-Spec basket are ones with long track records where I want to have some exposure in the portfolio but I’m not confident enough to give each a full allocation.
New-Spec companies are typically stocks either new on the scene or representing a fairly new approach or sector, where, like Old-Spec, I want exposure but I don’t want a full allocation of any individual company.
Current Position Performance
Apple (AAPL)
+750.04%*
1st Buy 4/18/2013 @ $14.17
Current Per-Share: (-$60.81)*
Boeing (BA)
+645.51%*
1st Buy 2/14/2012 @ $79.58
Current Per-Share: (-$162.30)*
Nvidia (NVDA)
+580.84%*
1st Buy 9/6/2016 @ $15.77
Current Per-Share: (-$13.45)*
Block (SQ)
+502.38%*
1st Buy 8/5/2016 @ $11.10
Current Per-Share: (-$75.30)*
Nike (NKE)
+449.66%*
1st Buy 2/14/2012 @ $26.71
Current Per-Share: (-$6.70)*
Logitech (LOGI)
+425.93%
1st Buy 11/11/2016 @ $24.20
Current Per-Share: $11.71
IDEXX Labs (IDXX)
+380.04%*
1st Buy 7/26/2017 @ $167.29
Current Per-Share: (-$112.25)*
Tesla (TSLA)
+361.51%*
1st Buy 3/12/2020 @ $37.10
Current Per-Share: (-$31.40)*
Skyworks (SWKS)
+319.46%*
1st Buy 1/31/2020 @ $113.60
Current Per-Share: (-$35.11)*
Disney (DIS)
+189.03%
1st Buy 2/14/2012 @ $41.70
Current Per-Share: $30.45
JP Morgan (JPM)
+96.32%
1st Buy 10/26/2017 @ $102.30
Current Per-Share: $66.87
Berkshire (BRK.B)
+63.23%
1st Buy 8/2/2019 @ $199.96
Current Per-Share: $187.77
Dow (DOW)
+59.19%
1st Buy 5/13/2019 @ $53.18
Current Per-Share: $31.95
Meta (META)
+56.47%*
1st Buy 9/16/2017 @ $128.58
Current Per-Share: -($64.60)*
Morgan Stan (MS)
+31.57%
1st Buy 4/25/2022 @ $83.50
Current Per-Share: $65.45
Take Two (TTWO)
+28.62%
1st Buy 10/9/2018 @ $128.40
Current Per-Share: $77.61
Schwab (SCHW)
+18.85%
1st Buy 4/18/2022 @ $76.30
Current Per-Share: $71.40
Visa (V)
+17.86%
1st Buy 5/9/2022 @ $194.00
Current Per-Share: $174.63
Amazon (AMZN)
+15.05%
1st Buy 2/6/2018 @ $69.15
Current Per-Share: $74.10
Salesforce (CRM)
+12.80%
1st Buy 6/11/2018 @ $134.05
Current Per-Share: $114.75
Zoetis (ZTS)
-2.02%
1st Buy 6/13/2022 @ $157.55
Current Per-Share: $148.75
SoFi (SOFI)
-3.96%
1st Buy 11/22/2022 @ $4.80
Current Per-Share: $4.80
Alphabet (GOOGL)
-7.96%
1st Buy 9/16/2022 @ $101.93
Current Per-Share: $96.95
Dutch Bros (BROS)
-16.73%
1st Buy 9/20/2021 @ $42.25
Current Per-Share: $36.10
Roblox (RLBX)
-40.65%
1st Buy 9/29/2021 @ $77.00
Current Per-Share: $45.07
Rivian (RIVN)
-51.23%
1st Buy 11/12/2021 @ $127.00
Current Per-Share: $39.25
Twilio (TWLO)
-53.07%
1st Buy 8/8/2019 @ $125.71
Current Per-Share: $95.35
Canopy (CGC)
-56.85%
1st Buy 5/24/2018 @ $29.53
Current Per-Share: $5.40
Coinbase (COIN)
-81.96%
1st Buy 4/14/2021 @ $412.47
Current Per-Share: $196.75
* Indicates a position where the capital investment was sold.
Profit % for * positions = Total Profit / Starting Capital Investment
A negative share price indicates the dollar amount of profit for each share currently held.
This Week’s Moves
Amazon (AMZN): Added to Position
Amazon (AMZN) broke down to new lows for 2022 on Thursday, triggering my next buy order which filled at $83.81.
The buy raised my per-share cost +1.42% from $72.20 up to $74.10. From here, my next buy target is my new cost basis at $74.10, and my next sell target is $103.23, just below the high from AMZN’s most recent rally.
AMZN closed the week at $85.25, up +1.72% from where I added Thursday.
Dow (DOW): Profit-Taking
I continued my more aggressive profit-taking strategy in Dow (DOW) this week, kicking it off on Monday with a sell order that cleared at $50.13. Once again, I’m executing sales at key price points to sell off some of the dividends this amazing stock yields in order to pull more capital out of the position and reduce my cost basis.
Monday’s sale lowered my per-share cost -0.78% from $32.20 to $31.95. From here, my next sell target is $53.00, just under a recent point of resistance, and my next buy target is below my cost basis at $31.05, above a key point of past support.
DOW closed the week at $50.86, up +1.46% from where I took profits Monday.
Dutch Bros (BROS): Added to Position
The selloff in Dutch Bros (BROS) continued this week with the stock price dipping a bit below $30.00 and triggering my next buy order which filled at $29.10 on Monday. The buy lowered my per-share cost -1.37% from $36.60 to $36.10.
From here, my next buy target is $24.90, above a past point of support, and my next sell target is $38.90, below the resistance BROS saw in its most recent rally.
BROS closed the week at $30.06, up +3.30% from where I added Monday.
Rivian (RIVN): Added to Position x 2
Rivian’s (RIVN) never-ending decline continued this week with the stock triggering my next buy order which filled at $21.40 on Tuesday. The small buy lowered my per-share cost -3.82% from $55.00 to $52.90.
However, RIVN was far from down selling off, breaking to new lows for 2022 on Thursday, triggering my next buy – a much larger quantity – at $19.39 on its way down. This gave me an average buy price of $19.56 and lowering my per-share cost -25.80% from $52.90 to $39.25, a price reduction for the week of -28.64% and a total reduction of -69.10% from where I initially opened the position at $127.00 on November 12, 2021.
From here, my next buy target is $15.10, above the key psychological support provided by $15.00, and my next sell target is $40.50, below RIVN’s high in August 2022.
RIVN closed the week at $19.14, down -2.15% from my $19.56 average buy price.
Schwab (SCHW): Profit-Taking
When Schwab (SCHW) rallied into the end of the week, my bearish perspective and discipline took over and it was time to take profits with a sale that went through at $81.97 on Friday. While the sale only locked in +7.43% in gains on some of the shares I bought when I initially opened the position for $76.30 on April 18, my bearish outlook going into the new year dictated profits must be taken.
The sale lowered my per-share cost -3.64% from $71.40 to $68.80. From here, my next sell target is around $92.50, below a previous point of resistance, and my next buy target is $65.55, right above SCHW’s low in October.
SCHW closed the week at $81.77, down -0.24% from where I took profits Friday.
Tesla (TSLA): Added to Position
Tesla’s (TSLA) death-defying drop since CEO Elon Musk bought Twitter, the social media platform, has been something to behold. In fact, despite my lack of faith in Musk in the short-term, TSLA dropped so much that it triggered my next buy order which filled at $121.82 on Friday.
The buy locked in an astounding -35.97% discount replacing shares I sold less than a month ago at $190.25 on November 30. The buy raised my per-share “cost” +$12.75 from -$44.15 to -$31.40 (a negative per-share cost indicates all capital has been removed in addition to $31.40 per share added to the portfolio’s bottom line in addition to each share’s current value).
From here, my next buy target is $91.25, above a past point of resistance, and my next sell target is $198.75, just below TSLA’s high from its last pop earlier in November.
TSLA closed the week at $123.15, up +1.09% from where I added Friday.
Want Further Clarification?
As always, if you have questions about any of my positions or have positions of your own that you’re curious about – feel free to leave a comment below!
See you next week!
Ways to give back to GetIrked:
Send me a tip via Stripe! Thank you!
Get free money by signing up for an account with my referral link for Schwab
Sign up for Gemini and we each get $10
Click this referral link to get the Brave Browser
If you use Brave, you can also use the Tip function to tip me in Basic Attention Token (BAT).
Get Irked is a small community made up of helpful, friendly and motivated investors and traders of all levels looking to reach the same goal – the ability to invest profitably in order to achieve financial independence.
Investors of ALL experience levels are welcome.
Join Get Irked by clicking here!
Disclaimer: Eric “Irk” Jacobson and all other Get Irked contributors are not investment or financial advisers. All strategies, trading ideas, and other information presented comes from non-professional, amateur investors and traders sharing techniques and ideas for general information purposes.
As always, all individuals should consult their financial advisers to determine if an investing idea is right for them. All investing comes with levels of risk with some ideas and strategies carrying more risk than others.
As an individual investor, you are accountable for assessing all risk to determine if the strategy or idea fits with your investment style. All information on Get Irked is presented for educational and informational purposes only.
You must be logged in to post a comment.